1. Home
  2. PDFS vs NVCR Comparison

PDFS vs NVCR Comparison

Compare PDFS & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$65.90

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$14.20

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
NVCR
Founded
1992
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
PDFS
NVCR
Price
$65.90
$14.20
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$39.67
$28.08
AVG Volume (30 Days)
730.6K
1.4M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
0.12
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$22.13
$7.72
Revenue Next Year
$18.92
$6.74
P/E Ratio
$548.04
N/A
Revenue Growth
N/A
8.28
52 Week Low
$18.19
$9.82
52 Week High
$66.98
$18.92

Technical Indicators

Market Signals
Indicator
PDFS
NVCR
Relative Strength Index (RSI) 67.79 36.95
Support Level $25.86 $12.66
Resistance Level N/A $15.46
Average True Range (ATR) 4.02 1.04
MACD 0.64 -0.27
Stochastic Oscillator 91.60 8.87

Price Performance

Historical Comparison
PDFS
NVCR

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: